gp140 vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02304185)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gp140 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02315703 | Phase 2 | Dec 22, 2014 | Crucell, Harvard University, International AIDS Vaccine Initiative, National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT02304185 | Phase 1 | Dec 1, 2014 | Crucell, Harvard University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Crucell | For profit | 2 | 2 | 2 | 2014 |
| Harvard University | Academic/Hospital | 2 | 0 | 2 | 2014 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 0 | 2 | 2014 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2014 |
| United States Army | Government | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1